Ibandronic Acid Synthon

Ibandronic acid, the active ingredient in Ibandronic Acid Synthon, is a bisphosphonate presented as an oral tablet for oral use. It treats postmenopausal osteoporosis, prevents bone loss in patients receiving glucocorticoid therapy, and is used for osteoporosis in men.\n\nGNH India supplies Ibandronic Acid Synthon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibandronic acid is a bisphosphonate used to manage conditions involving increased bone resorption.\n\n- Postmenopausal osteoporosis: reduces fracture risk by inhibiting bone loss.\n- Glucocorticoid‑induced osteoporosis: prevents bone loss associated with long‑term glucocorticoid therapy.\n- Male osteoporosis: improves bone density and lowers fracture incidence in men with osteoporosis.

Ibandronic acid may cause a range of adverse reactions, varying from mild to severe.\n\nCommon Side Effects:\n- Gastrointestinal irritation: nausea, abdominal pain, dyspepsia.\n- Musculoskeletal pain: bone, joint, or muscle discomfort.\n- Flu‑like symptoms: transient fever, chills, myalgia.\n- Headache: mild to moderate intensity.\n\nSerious or Rare Side Effects:\n- Osteonecrosis of the jaw: exposed bone in the maxillofacial region.\n- Atypical femoral fracture: low‑energy fracture of the subtrochanteric femur.\n- Severe hypersensitivity: anaphylaxis or angioedema.

Before prescribing ibandronic acid, clinicians should consider several safety factors.\n\n- Renal function: assess creatinine clearance prior to initiation.\n- Calcium/vitamin D status: ensure adequate supplementation to reduce hypocalcemia risk.\n- Concomitant bisphosphonates: avoid using other bisphosphonates concurrently.\n- Dental procedures: obtain dental evaluation; postpone invasive procedures when possible.\n- Pregnancy and lactation: use only if clearly needed; limited safety data are available.\n- Store at ambient temperature: keep below 25 °C in the original pack, protect from moisture.

Ibandronic acid can interact with several medicines, affecting absorption or renal handling.\n\nMajor Interactions (Avoid):\n- Calcium or multivitamin supplements: taken simultaneously reduces absorption; separate by at least 2 hours.\n- Antacids containing aluminum or magnesium: impair oral bioavailability; avoid co‑administration.\n- Renal‑clearing drugs (e.g., aminoglycosides, NSAIDs): increase risk of renal toxicity.\n\nModerate Interactions (Monitor Closely):\n- Corticosteroids: may enhance risk of osteonecrosis of the jaw; monitor oral health.\n- Warfarin: potential for altered INR; check coagulation parameters regularly.\n- Diuretics (loop): may affect calcium balance; monitor serum calcium.